¹û¶³´«Ã½

Bioventix assured as industry demand wavers

The biotech firm has awarded another special dividend

Vertu back in a giving mood

The car dealer is navigating supply-side issues and wider labour shortages

GSK malaria vaccine to roll-out following pilot programme

The World Health Organization gives the green light

FW Thorpe profits as challenges mount

The lighting specialist has had to contend with a range of challenges

Wetherspoon still at the mercy of Whitehall

It would be overly optimistic to rule out further government lockdowns

Smiths well poised for renewed opportunities

Following restructuring measures, the group is in better trim to take advantage of a bounce-back in its end-markets

Pharma groups scramble for Covid-19 antivirals

If you failed to capture the earnings growth generated by the mRNA vaccine candidates, there are new therapies in the trial phase

Animalcare boosted by higher margin sales mix

The veterinary pharma group has been boosted by rising Southern European demand

Medica taps into procedure backlog

A huge clinical backlog underpins medium-term revenue growth

Judges Scientific scores across the board

The scientific instruments group is outstripping the record intake of 2019